Drug Products

FDA to Put Warning on Ortho Evra

The FDA will put a new warning on the Ortho Evra birth control patch in order to warn consumers and healthcare professionals that users may be at a much greater risk of blood clots when using the patch.
Dr. Daniel Shames, director of the FDA’s division of reproductive and urologic drug products, says updated labeling has been approved for the product to warn healthcare providers and patients that women who use it are exposed to to higher levels of estrogen than most birth control pills.

Website My Space fun for Kids but a Boon for Predators

The popular social networking website My Space, has experienced unprecedented growth in recent months. Kids and teens spend hours browsing the website talking to friends and meeting new ones. However, parents must be aware that sexual predators are using the site to make contact with these kids. As is typical with sexual predators, they use websites popular with teens in order to strike up relationships with them. I urge any parents with teenaged children to monitor their computer use and beware of this looming threat.

Ortho Evra Patch Maker Says Blood Clot Risk Doubles with Birth Control Patch

Women who use the Ortho Evra birth-control patch face twice the risk of developing blood clots as those who take the Pill, the patch’s manufacturer said late Thursday, citing recent company-funded research.
The finding comes from one of two studies comparing the patch and Pill, said Ortho Women’s Health & Urology, maker of the once-a-week patch, based in Raritan, N.J.

FDA: Certain Parkinson’s Drugs Lead to Greater Risk of Gambling

The FDA is reporting that certain drugs used to treat tremors associated with Parkinson’s disease actually increase the risk of pathological gambling. The latest results are consistent with earlier observations and add to evidence that Parkinson’s drugs may lead to impulsive behavior as they make up for depleted dopamine, a brain chemical whose deficiency marks the disease. The researchers found no reports of gambling problems for patients taking antipsychotic drugs, which inhibit dopamine.

Continue reading

FDA Warns Doctors About Trasylol

The FDA has issued a warning to doctors and patients about the adverse risks associated with the Bayer drug Trasylol. The drug is used to control bleeding in such surgical procedures as heart bypass surgery. The FDA highlighted two studies published last month, including one in the New England Journal of Medicine, which showed that the drug, sold under the brand name Trasylol, doubled the risk of kidney failure.

Continue reading